Douglas Rich brings over 23 years of Operations and Quality experience across the entire product lifecycle. He has served in leadership roles responsible for the development and commercialization of both biopharmaceuticals and small molecules in addition to serving in leadership roles in consent decree and warning letter remediation activities, and acquisition and site integration activities. Mr. Rich most recently served as Senior Vice President Operations at Kythera Biopharmaceuticals Inc. (acquired by Allergan PLC) responsible for Manufacturing, Quality, and Supply Chain functions. In 2014, he joined Kythera as Vice President Manufacturing. Prior to Kythera, he was Vice President Quality at Boehringer-Ingelheim from 2011-2014 working in both the Biopharmaceutical and Prescription Medicine Business Units. Mr. Rich spent over 18 years at Amgen Inc., in various roles within Operations including Global Operations Strategy, Site Quality Head, Manufacturing, and Quality Control. He holds a B.S. in Biology from the University of Southern California and an MBA from Pepperdine University.